Update on Delayed Myocarditis Study Results

We have been eagerly awaiting the findings of the Myocarditis study involving New Zealanders diagnosed with the condition following their covid-19 injection.  We have written about it before but wanted to provide an update.

In Dec 2022 the Ministry of Health webpage stated:

Results are expected to be published online by early 2023. Information on where you can read the results will be provided here when available. 

This was changed on 4 Apr 2023 to say:

Study enrolment has now closed. Thank you to everyone who participated. We are in the process of analysing the extensive data that was shared with us. Information on where you can read the results will be provided here when available.

The webpage was last updated on 4 April and so the message remains as above.

We have periodically sent emails asking how the study is progressing and when we will be able to review the results.  Below are the replies.  We are hearing from numerous Kiwis who have ongoing severe symptoms over a year later and are interested to know if they are anomalies.

Based on very worrying research data from around the world on myocarditis specifically, and rising all-cause deaths generally in all heavily jabbed countries, which NZDSOS has profiled extensively, our concerns seem justified. And a brand new study proves ongoing spike protein release for at least 6 months in some injected. The tardy and suspicious MoH behaviour simply adds to our worries for injected kiwis.

Responses From the Myocarditis and Pericarditis Study Team

17 Mar 2023

Thank you for your email.

We appreciate your interest in the results of the long-term outcomes of myocarditis and pericarditis after Pfizer COVID-19 vaccination study. This has been a comprehensive piece of work with many data points, and we are currently working to fully understand the large amount of information that participants have shared with us. We are very close to being able to share the results of this work and we thank you for your patience. Once the information is available we will update the webpage about the study [link] with details around where the results are published.

26 Jun 2023

Thank you for your email and my apologies for delayed response.

The study has now completed and we are going through the data. This has been a comprehensive piece of work with many data points, and we are currently working to fully understand the large amount of information that participants have shared with us. We are very close to being able to share the results of this work and we thank you for your patience. We will be in touch as soon as we are able to share update and the results with you.

Thank you for your patience.

29 Aug 2023

Thank you for your email. Apologies for late reply.

We appreciate that you have been waiting some time for the results of the study.

The study has now concluded and is currently undergoing a robust review process.  We will be in touch as soon as the review is finished, to update you regarding results.

We appreciate your patience.

Ngā mihi,

Myocarditis and pericarditis study team
National Immunisation Programme
National Public Health Service
īmēra: [email protected]

We wonder what the ‘robust review process‘ involves.

If you took part in the Myocarditis Study we would be interested to hear from you.  Please contact us via the website with the subject line ‘Myocarditis Study’.